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Insulin receptor substrate-1 (IRS-1) plays an essential
role in mediating the insulin signals that trigger mitogen-
esis, lipid synthesis, and uncoupling protein-1 gene ex-
pression in mouse brown adipocytes. Expression of IRS-3
is restricted mainly to white adipose tissue; expression of
this IRS protein is virtually absent in brown adipocytes.
We have tested the capacity of IRS-3 to mediate insulin
actions in IRS-1-deficient brown adipocytes. Thus, we ex-
pressed exogenous IRS-3 in immortalized IRS-1/ brown
adipocytes at a level comparable with that of endogenous
IRS-3 in white adipose tissue. Under these conditions,
IRS-3 signaling in response to insulin was observed, as
revealed by tyrosine phosphorylation of IRS-3, and the
activation of phosphatidylinositol (PI) 3-kinase associ-
ated with this recombinant protein. However, although
insulin promoted the association of Grb-2 with recombi-
nant IRS-3 in IRS-1/ cells, the exogenous expression of
this IRS family member failed to activate p42/44 MAPK
and mitogenesis in brown adipocytes lacking IRS-1.
Downstream of PI 3-kinase, IRS-3 expression restored in-
sulin-induced Akt phosphorylation, which is impaired by
the lack of IRS-1 signaling. Whereas the generation of
IRS-3 signals enhanced adipocyte determination and dif-
ferentiation-dependent factor 1/sterol regulatory ele-
ment-binding protein (ADD-1/SREBP-1c) and fatty acid
synthase mRNA and protein expression, activation of this
pathway was unable to reconstitute CCAAT/enhancer-
binding protein  and uncoupling protein-1 transactiva-
tion and gene expression in response to insulin. Similar
results were obtained following insulin-like growth fac-
tor-I stimulation. In brown adipocytes expressing the
IRS-3F4 mutant, the association of the p85 regulatory
subunit via Src homology 2 binding was lost, but insulin
nevertheless induced PI 3-kinase activity and Akt phos-
phorylation in a wortmannin-dependent manner. In con-
trast, activation of IRS-3F4 signaling failed to restore the
induction of ADD-1/SREBP-1c and fatty acid synthase
gene expression in IRS-1-deficient brown adipocytes.
These studies demonstrate that recombinant IRS-3 may
reconstitute some, but not all, of the signals required for
insulin action in brown adipocytes. Thus, our data further
implicate a unique role for IRS-1 in triggering insulin
action in brown adipocytes.
Brown adipose tissue (BAT)1 is a unique site for non-shiver-
ing thermogenesis in mammals characterized by the expres-
sion of the uncoupling protein-1 (UCP-1) in the mitochondria
(1). UCP-1 uncouples fatty acid oxidation from ATP synthesis,
which allows dissipation of energy from substrate oxidation as
heat (2). In addition, BAT is a major site for lipid metabolism,
using fatty acids as the main fuel to maintain its thermogenic
capacity (for review see Ref. 3). Rodent brown adipocytes dif-
ferentiate at the end of the fetal life via two programs, an
adipogenic program of lipid synthesis and expression of lipo-
genic enzymes, which generates the multi-locular fat droplets
phenotype (4–6), and a thermogenic program related to heat
production and UCP-1 expression (7). Regarding thermogenic
differentiation, the main pathway involved in the regulation of
UCP-1 gene expression is noradrenergic (8–11). However, be-
cause the noradrenergic stimulus induced by hypothermia af-
ter birth is not yet fully developed in brown adipose tissue
during late fetal development (5, 9), other potential modulators
of differentiation-related gene expression have been consid-
ered. Recently (12, 13), regulatory elements for triiodothyro-
nine and retinoic acid have been identified in the UCP-1 pro-
moter, suggesting alternative pathways for brown fat
thermogenesis. Moreover, during recent years (6) our labora-
tory has found that fetal brown adipocytes display high affinity
binding sites for insulin. This classic hormone appears to be the
primary mediator of fetal brown adipogenesis based on its
ability to induce expression of metabolic genes (6, 14); insulin
may additionally exert a role in thermogenesis by inducing
UCP-1 expression (15).
Previous work from our laboratory has demonstrated that
primary fetal brown adipocytes express high levels of both
IRS-1 and IRS-2. Interestingly, IRS-1, but not IRS-2, associates
with Grb-2 in these cells to trigger ras/MAPK activation,
thereby mediating the mitogenic response to insulin. The PI
3-kinase cascade is the main pathway implicated in the expres-
sion of both adipogenic- and thermogenic-related genes in pri-
mary fetal brown adipocytes (16). In addition, ras/MAPK sig-
naling has been shown to down-regulate the UCP-1 gene
expression in response to insulin (17). Recently (18), we have
generated immortalized fetal brown adipocyte cell lines from
IRS-1 knockout. This cell culture model has enabled us to
identify the IRS-mediated signaling pathways responsible for
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the biological effects of insulin on brown adipose tissue during
late fetal development. Thus, in brown adipocyte cell lines
displaying the typical multilocular lipid droplets phenotype,
IRS-1, but not IRS-2, is essential for insulin-stimulated mito-
genesis (19), lipid synthesis (18), and also UCP-1 gene expres-
sion (20). No information is currently available regarding the
role of IRS-3 in the insulin signaling cascades of brown adipo-
cytes. IRS-3 was identified based on its specific expression in
rat white adipose tissue (21) where it plays a major role in
GLUT4 translocation and glucose transport in primary adipo-
cytes (22, 23). IRS-3 mediates PI 3-kinase activation rather
than Grb-2/ras signaling pathway, suggesting a specific role for
IRS-3 in triggering the metabolic rather than the mitogenic
actions of insulin (24).
In the current study, we have addressed the potential of
IRS-3 to mediate insulin signaling in brown adipocytes defi-
cient for IRS-1. Our results reveal that expression of recombi-
nant IRS-3 in our brown adipocyte model restores insulin-
stimulated Akt activation and fatty acid synthase gene
expression but not p42/p44 MAPK activation and UCP-1 gene
expression, critical pathways that are impaired in brown adi-
pocytes lacking IRS-1. Thus, these observations further con-
firm a unique role for IRS-1 in triggering insulin action in
brown adipose tissue.
EXPERIMENTAL PROCEDURES
Materials—Fetal calf serum (FCS) and culture media were obtained
from Invitrogen. Insulin, hygromycin, polybrene, anti--actin (A5441),
and anti-mouse IgG-agarose were from Sigma. Protein A-agarose was
from Roche Applied Science. IGF-I and TGF- were from Calbiochem.
The anti-IRS-3 antibodies (JD-363, -312, and -299) were a generous gift
from K. Kriaciunas and C. R. Kahn (Joslin Diabetes Center, Boston,
MA). The anti-Tyr(P) (clone 4G10; 05–321) and anti-p85 (clone
UB93-3; 05–217) antibodies were purchased from Upstate Biotechnol-
ogy, Inc. (Lake Placid, NY). The anti-Tyr(P) (Py20) (sc-508), anti-Grb-2
(sc-255), anti-C/EBP (sc-61), anti-ADD-1/SREBP-1c (sc-8984) antibod-
ies were purchased from Santa Cruz Biotechnology, Inc. (Palo Alto, CA.)
The anti-phospho-Akt (Ser-473; catalog number 9271), anti-Akt (cata-
log number 9272), anti-phospho-MAPK (Thr-202/Tyr-204; catalog num-
ber 9101), and anti-MAPK (catalog number 9102) antibodies were pur-
chased from Cell Signaling (Beverly, MA). The anti-UCP-1 (AB3038)
antibody was from Chemicon (Temecula, CA). The anti-cytochrome c
antibody (65981) was from BD Biosciences. [-32P]ATP (3000 Ci/mmol),
[-32P]dCTP (3000 Ci/mmol), and [3H]thymidine (0.2 Ci/ml; 1 M)
were from Amersham Biosciences. All other reagents used were of the
purest grade available.
Cell Culture and Retroviral Infections—Immortalized fetal brown
adipocyte cell lines derived from wild-type and IRS-1-deficient mice
have been generated as described previously (18). Viral Bosc-23 pack-
aging cells were transfected at 70% confluence by calcium phosphate
coprecipitation with 3 g/6-cm dish of the hygromycin-resistance retro-
viral vector pBabe encoding wild-type IRS-3 (kindly provided by C. R.
Kahn, Joslin Diabetes Center, Boston, MA). Then, IRS-1-deficient
brown adipocytes (clone 4) were infected at 60% confluence with poly-
brene (4 g/ml)-supplemented virus. Selection with 200 g/ml hygro-
mycin was started 72 h after infection to generate stable cell lines, the
expression of IRS-3 being assessed by Western blot.
Transfections—IRS-1-deficient brown adipocytes (clone 4) were cul-
tured for 24 h in the presence of 10% FCS and then, when 60–70%
confluence was reached, cells were co-transfected with 10 g of pCIS2
IRS-3F4 and pBABE hygro constructs according to the calcium phos-
phate-mediated protocol. After 4–6 h of incubation, cells were shocked
with 3 ml of 15% glycerol for 2 min, washed, and then fed with Dulbec-
co’s modified Eagle’s medium-10% FCS. 24 h after transfection, hygro-
mycin (200 g/ml) was added to select stable transfectants. The expres-
sion of the IRS-3F4 mutant was assessed by Western blot.
Immunoprecipitations—Quiescent cells were treated without or with
several doses of insulin as indicated and lysed at 4 °C in 1 ml of lysis
buffer containing 10 mM Tris/HCl, 5 mM EDTA, 50 mM NaCl, 30 mM
sodium pyrophosphate, 50 mM NaF, 100 M Na3VO4, 1% Triton X-100,
and 1 mM phenylmethylsulfonyl fluoride, pH 7.6. Lysates were clarified
by centrifugation at 15,000  g for 10 min. After protein content
determination, equal amounts of protein (500–600 g) were immuno-
precipitated with the corresponding antibodies at 4 °C. The immune
complexes were collected on protein A-agarose or anti-mouse IgG-aga-
rose beads. Immunoprecipitates were washed with lysis buffer and
extracted for 5 min at 95 °C in 2 SDS-PAGE sample buffer (200 mM
Tris/HCl, 6% SDS, 2 mM EDTA, 4% 2-mercaptoethanol, 10% glycerol,
pH 6.8) and analyzed by SDS-PAGE.
Western Blotting—After SDS-PAGE, proteins were transferred to
Immobilon membranes and were blocked using 5% non-fat dried milk or
3% bovine serum albumin in 10 mM Tris/HCl, 150 mM NaCl pH 7.5, and
incubated overnight with several antibodies as indicated in 0.05%
Tween 20, 10 mM Tris/HCl, 150 mM NaCl, pH 7.5. Immunoreactive
bands were visualized using the ECL Western blotting protocol (Amer-
sham Biosciences).
PI 3-kinase Activity—PI 3-kinase activity was measured in the anti-
IRS-3 or anti-Tyr(P) immunoprecipitates by in vitro phosphorylation of
phosphatidylinositol as described previously (18).
Protein Determination—Protein determination was performed by the
Bradford dye method (25) using the Bio-Rad reagent and bovine serum
albumin as the standard.
RNA Extraction and Northern Blot Analysis—Cells were cultured as
described under “Results” and in the figure legends. At the end of the
culture time, cells were washed twice in ice-cold phosphate-buffered
saline, and RNA was isolated as described (26). Total cellular RNA (10
g) was submitted to Northern blot analysis, i.e. electrophoresed on
0.9% agarose gels containing 0.66 M formaldehyde, transferred to Ge-
neScreen membranes (PerkinElmer Life Sciences), and cross-linked to
the membranes by ultraviolet light. Hybridization was performed in
0.25 mM NaHPO4, pH 7.2, 0.25 M NaCl, 100 g/ml denatured salmon
sperm DNA, 7% SDS, and 50% deionized formamide, containing dena-
tured 32P-labeled cDNA (106 cpm/ml) for 24 h at 42 °C. cDNA labeling
was carried out with [-32P]dCTP by using a multiprimer DNA-labeling
system. Blots were hybridized with probes for fatty acid synthase (FAS)
(27) and for ADD-1/SREBP-1c (28). Membranes were subjected to au-
toradiography, and the relative densities of the hybridization signals
were determined by densitometric scanning of the autoradiograms.
Extraction of Nuclear Proteins—At the end of the culture time, cells
were resuspended at 4 °C in Buffer A (10 mM HEPES-KOH, pH 7.9, 1.5
mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsul-
fonyl fluoride, 0.75 g/ml leupeptin, 0.75 g/ml aprotinin), allowed to
swell on ice for 10 min, and then vortexed for 10 s. Samples were
centrifuged, and the pellet was resuspended in cold Buffer C (20 mM
HEPES-KOH, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2
mM EDTA, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluo-
ride, 0.75 g/ml leupeptin, 0.75 g/ml aprotinin) and incubated on ice
for 20 min for high salt extraction. Cellular debris was removed by
centrifugation for 2 min at 4 °C, and the supernatant fraction was
stored at 70 °C.
Isolation of Mitochondrial Protein—Cells were cultured as described
under “Results” and in the figure legends. At the end of the culture
time, cells were scrapped off in isotonic isolation buffer (1 mM EDTA, 10
mM HEPES, 250 mM sucrose, pH 7.6), collected by centrifugation at
2,500  g for 5 min at 4 °C, and resuspended in hypotonic isolation
buffer (1 mM EDTA, 10 mM HEPES, 50 mM sucrose, pH 7.6). Then, cells
were incubated at 37 °C for 5 min and homogenized under a Teflon
pestle (Overhead Stirrer; Wheaton Instruments, Milville, NJ). Hyper-
tonic isolation buffer (1 mM EDTA, 10 mM HEPES, 450 mM sucrose, pH
7.6) was added to balance the tonicity of the buffer. Samples were
centrifuged at 10,000  g for 10 min, and the pellets, containing the
mitochondrial fraction, were resuspended in isotonic isolation buffer,
and mitochondrial protein content was determined.
CAT Assays—Cells growing in the presence of 10% FCS were tran-
siently transfected according to the calcium phosphate-mediated proto-
col as described previously (15). The plasmid constructs used were
UCP-1-CAT (where the CAT reporter gene is under the control of a
4551-bp full-length 5 flanking region of the UCP-1 promoter) (29) and
pCMV -galactosidase (gal) (a viral promoter driving expression of the
reporter gene -gal). Ten micrograms of DNA-CAT, together with 2 g
of DNA--gal (to monitor transfection efficiency), were added to each
10-cm dish. After 4 h of incubation, cells were fed with serum-free
medium for 15 h and stimulated with various doses of insulin or dibu-
tyryl cyclic AMP (Bt2cAMP) for a further 24 h. Then, cells were har-
vested, and lysates were prepared for CAT and -gal activity assays.
CAT activity was determined by incubating 70 l of cell extracts with
0.25 Ci of [14C]chloramphenicol and 0.5 mM acetyl coenzyme A in 0.25
mM Tris, pH 7.8, at 37 °C for 15 h, and then samples were submitted to
thin layer chromatography. The amount of substrate acetylated was
directly quantified with a radioimaging device (Fujifilm BAS-1000).
CAT enzyme activity was expressed in arbitrary units normalized to the
internal control -gal (assayed according to the Stratagene protocol).
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Transfections were performed in duplicate from three independent
experiments.
Determination of [3H]Thymidine Incorporation into Acid-insoluble
Material—DNA synthesis was determined after 24 h of cell culture in
the absence or presence of various doses of insulin by [3H]thymidine
incorporation (0.2 Ci/ml) into acid-insoluble material over the last 4 h
of culture (19). Results are expressed as disintegrations per min/dish.
RESULTS
Expression of IRS-3 and Its Tyrosine Phosphorylation in
IRS-1-deficient Brown Adipocytes—Previous experiments per-
formed in IRS-1-deficient fetal brown adipocytes revealed an
essential role of IRS-1 in mediating insulin-induced lipid syn-
thesis (18) and UCP-1 expression (20), IRS-2 being unable to
compensate these responses. IRS-3 is a member of IRS family
mainly expressed in white adipose cells (21). IRS-3 expression
is virtually absent in BAT extracts, as shown in the Western
blot depicted in Fig. 1A. To investigate a possible role of IRS-3
in triggering insulin actions in IRS-1-deficient brown adipo-
cytes, we overexpressed IRS-3 in immortalized IRS-1/ brown
adipocytes by retroviral gene transfer. By using this approach,
we generated immortalized fetal brown adipocyte IRS-1-defi-
cient cell lines expressing similar IRS-3 levels than those found
in white adipose tissue extracts (see Fig. 1A). Our next step was
to investigate whether overexpressed IRS-3 in IRS-1-deficient
brown adipocytes undergoes tyrosine phosphorylation upon in-
sulin stimulation. Confluent immortalized brown adipocytes
(wild-type, IRS-1/, IRS-1/(IRS-3)) were serum-deprived
for 20 h and then stimulated with insulin (10–100 nM) for 5
min. Total protein was immunoprecipitated with anti-IRS-3
antibody and submitted to Western blot analysis with the anti-
Tyr(P) antibody. As shown in Fig. 1B, insulin induced a marked
increased in IRS-3 tyrosine phosphorylation in IRS-1/ brown
adipocytes overexpressing IRS-3, no tyrosine phosphorylation
of IRS-3 being detected either in immortalized wild-type or
IRS-1/ brown adipocytes.
Insulin Induced the Association of IRS-3 with p85a and
Activated PI 3-kinase in IRS-1-deficient Brown Adipocytes—
IRS-3 contains phosphotyrosine residues in a consensus se-
quence for binding to p85 regulatory subunit of PI 3-kinase
following insulin stimulation (23). Accordingly, we investigated
whether overexpressed IRS-3 associated p85 in immortalized
IRS-1/(IRS-3) fetal brown adipocytes. Serum-deprived
cells were further stimulated with insulin (10–100 nM) for 5
min. Total protein was immunoprecipitated with anti-IRS-3
antibody and submitted to SDS-PAGE followed by Western blot
with anti-p85 antibody. In the representative experiment
shown in Fig. 2A, we did not detect association of p85 with
IRS-3 in wild-type brown adipocytes stimulated with insulin.
Surprisingly, insulin stimulation of IRS-1/ brown adipocytes
resulted in a slight increase in p85 associated to IRS-3, de-
spite of the absence of tyrosine-phosphorylated IRS-3 in these
cells (see Fig. 1B). As expected, overexpressed IRS-3 in IRS-
1/ brown adipocytes associated p85 in parallel to the levels
of its tyrosine phosphorylation. Next, we checked whether
IRS-3 was able to activate PI 3-kinase in brown adipocytes.
FIG. 1. Exogenous expression of IRS-3 in IRS-1-deficient brown adipocytes. A, IRS-1/ brown adipocytes were cultured in the presence
of 10% FCS to 80% confluence. Then, cells were infected with the retroviral expression vector pBabe-IRS-3-hygro for 5 h. After infection, brown
adipocytes were maintained in culture medium for 72 h before selection with hygromycin (200 g/ml). Stable resistant cells were expanded and
cultured under growing conditions. Cells were lysed, and 100 g of total protein was submitted to SDS-PAGE and analyzed by Western blot with
the anti-IRS-3 antibody. Lanes 1 and 2 are controls of freshly isolated white and brown adipose tissue extracts (WAT and BAT, respectively). An
arrowhead indicates the position of IRS-3. The position of molecular weight markers ( 103) is shown on the left. A representative experiment
is shown. Scanning densitometry of the mean of three independent experiments is shown on the right. B, IRS-1/ and IRS-1/(IRS-3) brown
adipocytes were serum-starved for 15 h, stimulated for 5 min with insulin (10–100 nM), and lysed. 600 g of total protein was immunoprecipitated
with the anti-IRS-3 antibody. The immune complexes were submitted to Western blot analysis with anti-Tyr(P) and anti-IRS-3 antibodies,
respectively. A representative experiment of three is shown.
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Cells were stimulated as described above, and PI 3-kinase
activity was measured in anti-IRS-3 immune complexes as
described under “Experimental Procedures.” As shown in Fig.
2B (left panel), IRS-3-associated PI 3-kinase enzymatic activity
in parallel to IRS-3/p85 association. Although no IRS-3-asso-
ciated PI 3-kinase activity was detected in wild-type cells, in
IRS-1/ brown adipocytes insulin slightly induced IRS-3-as-
sociated PI 3-kinase activity in a dose-dependent manner, this
effect being much higher when IRS-3 was overexpressed in
these cells. Our laboratory has reported recently (18, 20) that
the lack of IRS-1 resulted in a 30% decrease in total (anti-
Tyr(P)-associated) PI 3-kinase activity in insulin-stimulated
brown adipocytes. To test whether IRS-3 can replace IRS-1 in
stimulating total PI 3-kinase activity in fetal brown adipocytes,
cells were treated with insulin (10–100 nM) for 5 min and
further assayed for PI 3-kinase enzymatic activity in anti-
Tyr(P) immune complexes. Fig. 2B (right panel) showed that
IRS-3 expression in IRS-1/ brown adipocytes turned out in a
recovery of total PI 3-kinase activity, this effect being truly
significant at 100 nM insulin concentration.
IRS-3 Expression Restored the Insulin Effect on Akt Phospho-
rylation, but Not MAPK Activation, in IRS-1/ Brown Adipo-
cytes—In fetal brown adipocytes, the lack of IRS-1-associated
PI 3-kinase activity cannot be compensated by IRS-2 and re-
sults in a failure of insulin to stimulate downstream targets
such as Akt phosphorylation (18, 20). The fact that IRS-3 binds
to and activates PI 3-kinase in IRS-1/ cells prompted us to
investigate a possible mechanism of recovery of the insulin
response in activating Akt in the absence of IRS-1. Cells were
stimulated with various doses of insulin and subsequently ly-
sed. AktSer-473 phosphorylation was determined by direct West-
ern blot analysis in wild-type, IRS-1/, and IRS-1/(IRS-3)
cells (Fig. 3A). In fetal brown adipocytes, the lack of IRS-1
resulted in a loss of AktSer-473 phosphorylation; only a remnant
AktSer-473 phosphorylation was detected at 100 nM insulin con-
centration. The exogenous expression of IRS-3 in IRS-1/
brown adipocytes resulted in a total recovery of AktSer-473 phos-
phorylation in response to insulin.
It has been extensively reported that the association of IRS
proteins with Grb-2 results in the activation of MAPK (30). In
fact, we have shown recently (19) that in brown adipocytes the
effect of insulin on MAPK activation is IRS-1-dependent. Ac-
cordingly, we investigated whether IRS-3 led to activation of
MAPK in brown adipocytes. First, we checked IRS-3/Grb-2
association in IRS-1/ brown adipocytes expressing IRS-3.
Cells were stimulated with various doses of insulin and then
lysed. Total protein (600 g) was immunoprecipitated with
anti-Grb-2 antibody and analyzed by Western blot with anti-
IRS-3 antibody. As shown in Fig. 3B, there was no IRS-3/Grb-2
association either in wild-type or IRS-1/ brown adipocytes.
However, insulin-stimulated IRS-1/ cells expressing exoge-
nous IRS-3 showed a marked IRS-3/Grb-2 association (Fig. 3B,
upper panel). Next, we measured MAPK phosphorylation in
IRS-1/ brown adipocytes in the presence of IRS-3. As shown
in a representative Western blot depicted in Fig. 3B (lower
panel), insulin increased MAPK phosphorylation in wild-type
cells but not in IRS-1/, as reported previously (19). The
expression of IRS-3 in IRS-1/ brown adipocytes did not result
FIG. 2. Association of IRS-3 to p85 in response to insulin and its contribution to PI 3-kinase activity in IRS-1/ brown adipocytes.
A, wild-type, IRS-1/(IRS-3), and IRS-1/ brown adipocytes were cultured to confluence under growing conditions and serum-starved for 15 h.
Quiescent cells were incubated for 5 min with insulin (10–100 nM) and then lysed. 600 g of total protein were immunoprecipitated with the
anti-IRS-3 antibody, and the resulting immune complexes were analyzed by Western blot with anti-p85 and anti-IRS-3 antibodies. A represent-
ative experiment of three is shown. B, serum-deprived brown adipocytes were stimulated with insulin (10–100 nM). Then, cells were lysed and
immunoprecipitated with anti-IRS-3 or anti-Tyr(P) antibodies, respectively. The immune complexes were used for an in vitro phosphatidylinositol
kinase assay as described under “Experimental Procedures.” Autoradiograms were quantitated by scanning densitometry. Results are expressed
as arbitrary units of PI 3-kinase activity and are means  S.E. of three to four independent experiments.
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in the activation of MAPK in response to insulin. Thymidine
incorporation into DNA revealed that insulin did not stimulate
DNA synthesis in IRS-1/ cells despite the presence of p42
phosphorylation background, and as compared with wild-type
cells, the expression of IRS-3 failed to restore mitogenesis.
IRS-3 Restored Insulin-induced Adipogenic-gene Expression
in IRS-1/ Brown Adipocytes—Insulin-induced adipogenic
differentiation program in brown adipocytes can be monitored
by the expression of a set of lipogenic enzymes including FAS
(5). In addition, insulin-induced FAS mRNA expression was
inhibited in the presence of PI 3-kinase inhibitors in primary
cultures of fetal brown adipocytes (15, 16) or in immortalized
fetal brown adipocytes lacking IRS-1 (20). Accordingly, we in-
vestigated whether the presence of IRS-3 in IRS-1/ cells
could positively affect lipogenic gene expression. Cells were
cultured for 12 and 24 h in the presence of various doses of
insulin, and FAS mRNA and protein content were assessed by
Northern and Western blot analysis, respectively. As shown in
Fig. 4A, insulin treatment for 12 h induced FAS mRNA in
wild-type brown adipocytes in a dose-dependent manner, max-
imal effect being elicited at 100 nM insulin concentration. This
effect was abolished in IRS-1/ cells, as reported previously
(20). However, the expression of IRS-3 in IRS-1-deficient cells
resulted in a substantial up-regulation of FAS mRNA following
insulin stimulation, reaching similar levels than that of the
wild-type. At the protein level, IRS-3 led to a recovery of insu-
lin-induced FAS protein content. Because FAS expression has
been shown to be dependent on ADD1/SREBP-1c transcription
factor (31), we analyzed ADD1/SREBP-1c expression in the
presence of insulin in the three cell types. As shown in Fig. 4B,
both ADD-1/SREBP-1c mRNA and protein content (the nuclear
mature form of ADD-1/SREBP-1c) were increased after 12 h
(mRNA) or 24 h (protein content) of insulin treatment in wild-
type and IRS-1/(IRS-3) cells but not in IRS-1/ cells.
These results indicate that, in brown adipocytes, IRS-3 and its
signaling through PI 3-kinase up-regulated FAS expression as
a result of the increase in ADD1/SREBP-1c expression.
IRS-3 Failed to Restore UCP-1 Gene Expression in Response
to Insulin in IRS-1/ Brown Adipocytes—We have shown
previously (15, 16) that insulin is a novel thermogenic factor in
brown adipocyte primary cultures involved in UCP-1 expres-
sion during late fetal development in a PI 3-kinase-dependent
manner. Furthermore, the lack of IRS-1 in brown adipocytes
resulted in a loss of the insulin response in inducing UCP-1,
IRS-2 being unable to compensate this response (20). Based on
that, our next purpose was to define whether IRS-3 can replace
IRS-1 in mediating thermogenic-related gene expression in-
duced by insulin in brown adipocytes. UCP-1 protein content
was analyzed by direct Western blot analysis in mitochondrial
protein extracts of IRS-1/, IRS-1/, and IRS-1/(IRS-3)
FIG. 3. Exogenous expression of IRS-3 restores Akt phosphorylation, but not MAPK activation, in IRS-1/ brown adipocytes
following insulin stimulation. A, quiescent cells (15 h serum-starved) were stimulated with insulin (10–100 nM) for 5 min. Cells were lysed, and
50 g of total protein was submitted to SDS-PAGE and analyzed by immunoblotting with the corresponding antibodies against phospho-Akt
(Ser-473) and total Akt. The autoradiograms corresponding to four experiments were quantitated by scanning densitometry. Results are expressed
as arbitrary units of Akt phosphorylation and are means S.E. B, upper panel, quiescent cells were stimulated with insulin (10–100 nM) for 5 min.
Cell lysates were immunoprecipitated with the anti-Grb-2 antibody, and the resulting immune complexes were analyzed by Western blot with
anti-IRS-3 and anti-Grb-2 antibodies, respectively. A representative experiment of three is shown. Lower panel, serum-starved cells were incubated
without or with insulin (10–100 nM) for 5 min. Then, cells were lysed, and equal amounts of protein were submitted to SDS-PAGE followed by
Western blot analysis with anti-phospho-MAPK and anti-MAPK antibodies. A representative experiment of three is shown. Cells were cultured
for 24 h in serum-free medium either in the absence or presence of insulin (1–100 nM). DNA synthesis was determined by [3H]thymidine
incorporation (0.2 Ci/ml) over the last 4 h of culture. After two washes with ice-cold phosphate-buffered saline, cells were lysed, and trichloro-
acetate-precipitable DNA was then counted for incorporated radioactivity. Results are expressed as disintegrations/min/dish and are means S.E.
from six independent experiments, each one performed in triplicate.
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cell types upon insulin stimulation. As shown in Fig. 5A (left
panel), UCP-1 protein content was up-regulated by 24 h of
insulin treatment in wild-type brown adipocytes whereas in
IRS-1-deficient cells this response was completely blunted. In-
terestingly, the exogenous expression of IRS-3 in IRS-1-defi-
cient cells did not restore the insulin effect on UCP-1 protein
content. Another approach was to study the effect of insulin on
transactivating the UCP-1 promoter in the three cell types.
Cells were transiently transfected with the 4551-bp full-length
UCP-1 promoter driving the expression of the CAT reporter
gene (29). Upon transfection, cells were cultured for 24 h in a
serum-free medium either in the absence or presence of 100 nM
insulin and then CAT activity was determined. As shown in
Fig. 5A (right panel), the 4551-CAT fusion gene was weakly
transcribed in unstimulated wild-type brown adipocytes, insu-
lin treatment resulting in 2.5-fold increase in CAT activity.
IRS-1/ brown adipocytes lacked insulin stimulation of UCP-1
CAT activity, exogenous expression of IRS-3 being unable to
restore insulin-induced UCP-1 CAT activity. Regarding the
transcriptional machinery involved in the regulation of UCP-1,
the 5-flanking region of this gene contains C/EBP-regulated
sites (32). In fact, recent data from our laboratory (20) indicated
that C/EBP protein content was positively regulated by insu-
lin. Therefore, we performed anti-C/EBP Western blot analy-
sis in nuclear extracts from control and insulin-stimulated
brown adipocytes. As shown in Fig. 5B, the expression of
C/EBP was significantly up-regulated by 24 h of insulin treat-
ment in wild-type cells but not in IRS-1/ cells, regardless the
exogenous expression of IRS-3.
IRS-3 Restored FAS Expression, but Failed to Restore UCP-1
Gene Expression, in IRS-1/ Brown Adipocytes following
IGF-I Stimulation—Our next purpose was to investigate the
response of brown adipocyte cell lines to IGF-I regarding dif-
ferentiation-related gene expression. Cells were cultured for 12
and 24 h in the presence of 10 nM IGF-I, and FAS mRNA and
protein content were assessed by Northern and Western blot
analysis, respectively. As shown in Fig. 6A (upper panel), IGF-I
treatment for 12 h induced FAS mRNA in wild-type brown
adipocytes. This effect was blunted in IRS-1/ cells. However,
the expression of IRS-3 in IRS-1-deficient cells resulted in a
substantial up-regulation of FAS mRNA, reaching similar lev-
els than that of the wild-type. At the protein level, IRS-3
restored IGF-I-induced FAS protein content (Fig. 6A, middle
panel). As shown in Fig. 6A (lower panel), UCP-1 protein con-
FIG. 4. Overexpression of IRS-3 restores the insulin effect on FAS and ADD1/SREBP-1c expression in IRS-1/ brown adipocytes.
A, upper panel, quiescent wild-type, IRS-1/(IRS-3), and IRS-1/ brown adipocytes were serum-starved for 15 h and stimulated with insulin
(10–100 nM) for a further 12 h. Control cells were cultured in the absence of the hormone. Total RNA was isolated, submitted to Northern blot
analysis, and hybridized with FAS cDNA probe. A representative experiment is shown. Scanning densitometry of the mean of five independent
experiments is shown on the right. Brown adipocytes were serum-starved for 15 h and stimulated with insulin (10–100 nM) for 24 h. Lower panel,
at the end of the culture time, cells were lysed, and 50 g of total protein were submitted to SDS-PAGE followed by Western blot analysis with
anti-FAS and anti--actin antibodies. Representative autoradiograms are shown. Scanning densitometry of the mean of three-four independent
experiments is shown on the right. B, upper panel, quiescent wild-type, IRS-1/(IRS-3), and IRS-1/ brown adipocytes were serum-starved for
15 h and stimulated with insulin (10–100 nM) for a further 12 h. Control cells were cultured in the absence of the hormone. Total RNA was isolated,
submitted to Northern blot analysis, and hybridized with ADD-1/SREBP-1c cDNA probe. A representative experiment is shown. Scanning
densitometry of the mean of five independent experiments is shown on the right. Lower panel, brown adipocytes were serum-starved for 15 h and
stimulated with insulin (10–100 nM) for 24 h. At the end of the culture time cells were lysed, and 50 g of nuclear protein were submitted to
SDS-PAGE followed by Western blot analysis with anti-ADD-1/SREBP-1c and anti--actin antibodies. Representative autoradiograms are shown.
Scanning densitometry of the mean of three-four independent experiments is shown on the right.
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tent was up-regulated upon 24 h of IGF-I treatment in wild-
type brown adipocytes, whereas in IRS-1-deficient cells this
response was completely blunted. In addition, the exogenous
expression of IRS-3 in IRS-1-deficient cells did not restore the
IGF-I effect on UCP-1 protein content. Because of the negative
response of insulin or IGF-I in triggering UCP-1 expression and
to rule out the possibility of alterations in these cells, we
addressed the point of IRS-independent alternative signals. As
shown in Fig. 6B, TGF- induced FAS expression in wild-type
and IRS-1/ cells. More importantly, Bt2cAMP, a second mes-
senger of the -adrenergic pathway, induced UCP-1 protein
expression and UCP1-CAT transactivation at a similar extent
in both in wild-type and IRS-1/ cells.
Expression of the IRS-3F4 Mutant Failed to Associate p85
in Insulin-stimulated IRS-1/ Brown Adipocytes—Results
shown above indicate that IRS-3 can replace IRS-1 in main-
taining FAS and ADD1/SREBP-1c expression as a result of the
activation of PI 3-kinase/Akt signaling pathway. A step fur-
ther, we expressed an IRS-3 mutant (denoted IRS-3F4) in
which Phe substituted to the four Tyr residues in Tyr-Xaa-Xaa-
Met motifs (Tyr-341, Tyr-350, Tyr-361, and Tyr-390), which
bind to Src homology 2 domains of p85 regulatory subunit
(23). Importantly, the expression of IRS-3F4 was similar to
that of wild-type IRS-3 in IRS-1/ brown adipocytes (Fig. 7A).
Furthermore, mutation of these four tyrosines abolished the
association of p85 with IRS-3F4 as revealed by anti-p85
Western blot analysis of anti-IRS-3 immunoprecipitates follow-
ing insulin stimulation (Fig. 7A). Next, we checked whether
IRS-1/ brown adipocytes expressing IRS-3F4 were able to
induce PI 3-kinase activity and Akt phosphorylation. Quiescent
cells were stimulated with insulin (10–100 nM) for 5 min, and
PI 3-kinase activity was assayed in the anti-IRS-3 immune
complexes. Akt phosphorylation was determined by direct
Western blot with the anti-phospho-Ser-473 antibody. Insulin
induced both PI 3-kinase activity and Akt phosphorylation in
IRS-1/ brown adipocytes expressing IRS-3F4 to a similar
extend as that of the wild-type IRS-3 (Fig. 7B). Then, we
investigated whether IRS-3- and IRS-3F4-associated PI 3-ki-
nase activity was wortmannin-dependent. Fig. 7C shows that
both IRS-3- and IRS-3F4-associated PI 3-kinase activity and
Akt phosphorylation were prevented when cells were pre-
treated with wortmannin.
IRS-3F4 Mutant Failed to Restore Adipogenic Gene Expres-
sion in Insulin-stimulated IRS-1/ Brown Adipocytes—Fi-
nally, we explored the effect of overexpressing IRS-3F4 mutant
on IRS-1-deficient brown adipocytes regarding the adipogenic
phenotype. Cells (IRS-1/(IRS-3) and IRS-1/(IRS-3F4))
were stimulated with insulin for 12 and 24 h. Then, FAS and
ADD-1/SREBP-1c expression was analyzed by Northern and
Western blot, respectively. Fig. 8A shows that the expression of
the IRS-3F4 mutant did not restore the insulin effect regarding
FAS and ADD-1/SREBP-1c mRNA, as compared with the pos-
itive effect induced by wild-type IRS-3. These data were rein-
forced by those depicted in Fig. 8B, where no insulin effect was
observed on FAS and ADD-1/SREBP-1c protein content in IRS-
1-deficient brown adipocytes expressing IRS-3F4 mutant, as
compared with wild-type IRS-3.
FIG. 5. IRS-3 fails to restore C/EBP and UCP-1 gene expression in IRS-1/ brown adipocytes following insulin stimulation. A, left
panel, serum-starved brown adipocytes were stimulated with insulin (10–100 nM) for 24 h. Mitochondrial proteins were extracted, and equal
amounts of protein were submitted to SDS-PAGE and analyzed by Western blot with anti-UCP-1 and anti-cytochrome c antibodies. A represent-
ative experiment of three is shown. Right panel, wild-type, IRS-1/(IRS-3), and IRS-1/ brown adipocytes were transiently transfected with 10
g of full promoter UCP-1-CAT fusion gene. Upon transfection, cells were cultured for 24 h in serum-free medium in either the absence or presence
of insulin (10–100 nM). At the end of the culture period, cells were collected and assayed for CAT activity. The relative CAT activity normalized
to -gal activity is represented in the histograms. Results are means  S.E. from three independent experiments. B, quiescent brown adipocytes
were serum-starved for 15 h and further stimulated with insulin (10–100 nM) for 24 h. At the end of the culture, cells were lysed, and equal amounts
of nuclear protein were submitted to SDS-PAGE followed by Western blot analysis with the anti-C/EBP antibody. The autoradiograms
corresponding to four experiments were quantitated by scanning densitometry. Results are expressed as arbitrary units and are means  S.E.
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DISCUSSION
IRS-3 is the member of IRS family expressed mainly in white
adipose tissue (21) where it is detected at levels comparable
with IRS-1 (33). However, expression of IRS-3 in brown adipose
tissue and brown adipocyte cell lines appears to be much lower
than of IRS-1, as IRS-3 was barely detectable in control brown
adipocytes and those lacking IRS-1 (Fig. 1). Previous experi-
ments performed in IRS-1-deficient fetal brown adipocytes re-
vealed a critical role for IRS-1 in mediating insulin-induced
mitogenesis (19), lipid synthesis (18), and UCP-1 gene expres-
sion (20). In sharp contrast, IRS-2 was unable to trigger path-
ways responsible for the biological actions of insulin in these
cells. To investigate whether IRS-3 signals might substitute
the role of IRS-1 in mediating insulin action in IRS-1-deficient
brown adipocytes, we overexpressed IRS-3 in immortalized
IRS-1/ brown adipocytes by retroviral gene transfer. The
level of expression of IRS-3 in IRS-1/ brown adipocytes was
comparable with that detected in white adipose tissue (Fig. 1).
Under these conditions, insulin-responsive IRS-3 signaling was
established in our brown adipocyte model, as revealed by tyro-
sine phosphorylation of recombinant IRS-3 and the activation
of associated PI 3-kinase. Interestingly, in brown adipocytes
lacking IRS-1, we observed an enhanced association of p85
and corresponding activation of PI 3-kinase in immunoprecipi-
tates of endogenous IRS-3, given the minimal expression of
endogenous protein that we detected by Western blotting. The
augmented capacity of endogenous IRS-3 to recruit PI 3-kinase
may reflect its sub-cellular localization, which could be optimal
for generation of lipid second messengers. Nevertheless, this
IRS-3 signaling could not compensate for the absence of IRS-1
in mediating insulin-stimulated mitogenesis and lipid synthe-
sis in brown adipocyte cell lines.
Two major insulin signaling pathways have been described
in brown adipocytes. Insulin promotes IRS-1/Grb-2 association
and p42/44 MAPK activation, producing a mitogenic response
(19). Insulin also enhances IRS-1/IRS-2-dependent PI 3-kinase
activation and Akt phosphorylation, resulting in the stimula-
tion of lipid synthesis (18) and UCP-1 gene expression (20).
Insulin stimulated dose-dependently the association of Grb2
with exogenous IRS-3 in IRS-1/ brown adipocytes (Fig. 3B).
These data contrast the weak association between IRS-3 and
Grb-2 observed in white adipocytes, where IRS-3 and IRS-1 are
equally abundant (34). However, despite recruitment of Grb2,
the exogenous expression of IRS-3 in brown adipocytes lacking
IRS-1 failed to activate p42/44 MAPK and mitogenesis. These
data differ from those reported in IRS-1-deficient mouse 3T3
embryo fibroblasts, where the impaired mitogenic response to
IGF-I was reconstituted by supranormal levels of IRS-1 and
FIG. 6. Other stimuli, but not IGF-I, maintain the expression of adipogenic and thermogenic markers in IRS-1/ brown adipo-
cytes. A, upper panel, cells were serum-starved for 15 h and further cultured for 12 h in the absence or presence of IGF-I (10 nM). At the end of
culture period, total RNA was submitted to Northern blot analysis and hybridized with FAS cDNA probe. A representative experiment of three is
shown. Middle panel, brown adipocytes were serum-starved for 15 h and stimulated with IGF-I (10 nM) for 24 h. Cells were lysed, and 50 g of total
protein was submitted to SDS-PAGE followed by Western blot analysis with anti-FAS and anti--actin antibodies. Lower panel, cells were
serum-starved for 15 h and stimulated with or without IGF-I (10 nM) for 24 h. Mitochondrial protein extracts were analyzed by Western blot with
anti-UCP-1 and anti-cytochrome c antibodies. B, upper panel, wild-type and IRS-1-deficient brown adipocytes were serum-starved for 15 h and
further cultured for 24 h in the presence of several doses of TGF- (0.1–1 nM). Then, cells were collected, and equal amounts of protein were
analyzed by Western blot analysis with anti-FAS and anti--actin antibodies. Middle panel, quiescent wild-type and IRS-1-deficient brown
adipocytes were stimulated with Bt2cAMP (0.5 mM) for 24 h. At the end of this period, mitochondrial protein extracts were obtained and analyzed
by Western blot with anti-UCP-1 and anti-cytochrome c antibodies. Lower panel, wild-type and IRS-1-deficient brown adipocytes were transiently
transfected with 10 g of full promoter UCP-1-CAT fusion gene. Upon transfection, cells were cultured for 24 h in serum-free medium in either
the absence or presence of Bt2cAMP (0.5 mM). At the end of the culture period, cells were collected and assayed for CAT activity. The relative CAT
activity normalized to -gal activity is represented in the histograms. Results are the means  S.E. from three independent experiments.
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was restored to almost normal by IRS-3 expression (35). These
data strongly support the notion that IRS-1, but not IRS-3, is
an essential component of the brown adipocyte mitogenic re-
sponse to insulin, a pathway that is dependent on MAPK acti-
vation. Interestingly, IRS-3 overexpression reconstituted insu-
lin-induced Akt phosphorylation, a response impaired in brown
adipocytes lacking IRS-1 (Fig. 3A).
Diverging signals downstream of IRS-3 were observed in the
absence of IRS-1. Whereas the introduction of IRS-3 signals in
brown adipocytes led to an enhancement of insulin-mediated
ADD-1/SREBP-1c and FAS mRNA and protein expression, ex-
ogenous IRS-3 failed to restore the C/EBP and UCP-1 trans-
activation and gene expression in response to insulin (see Figs.
4 and 5, respectively). The inability of IRS-3 signaling to me-
diate thermogenic-related gene expression contrasts with re-
sults obtained by the exogenous expression of either C/EBP or
peroxisome proliferator-activated receptor  in IRS-1-deficient
brown adipocytes; both transcription factors induced UCP-1
expression in an insulin-independent manner (20). As insulin-
induced adipogenic differentiation program in brown adipo-
cytes can be monitored by the expression of a set of lipogenic
enzymes including FAS, our data suggest that IRS-3 may exert
a role in the induction of adipogenic-related gene expression by
insulin, with the regulation of ADD-1 expression representing
a critical step. Similarly, given that UCP-1 gene expression
reflects induction of thermogenic genes, our data demonstrate
that IRS-3 signaling is unable to mediate the effects of insulin
upon thermogenic-related gene expression in cells lacking
IRS-1 because of its failure to reconstitute expression of
C/EBP. The phenotypes of IRS-1 knockouts and IRS-1/IRS-3
double knockout mice have revealed dramatic differences in the
development and/or maintenance of white fat; IRS-1-deficient
mice develop a more or less normal white adipose tissue
whereas the double knockouts display profound lipoatrophy.
However, no differences in brown adipose tissue were observed
between these knockout models, which both develop brown
adipose tissue normally other than the fact that cells contain
smaller lipid depots (36). More importantly, brown adipose
tissue-specific deletion of the insulin receptor in mice (BAT-
IRKO) causes profound brown fat lipoatrophy because of a
significant reduction in lipid content, which appears to reflect
smaller cell size and enhanced eosinophilia. However, the ex-
pression of UCP-1 was significantly increased in BATIRKO
mice (37). Our current data are consistent with these later
observations, emphasizing the role of IRS-3 in generating the
insulin signals required for lipid synthesis but not for induction
FIG. 7. IRS-3F4 mutant does not associate with p85 in response to insulin but activates PI 3-kinase and Akt phosphorylation. A,
left, IRS-1/ brown adipocytes were transiently co-transfected with a plasmid encoding IRS-3F4 mutant, together with a hygromycin-resistant
retroviral vector. IRS-1/(IRS-3) and IRS-1/(IRS-3F4) brown adipocytes were cultured to confluence under growing conditions. Cells were
lysed, and equal amounts of protein (500 g) were immunoprecipitated with the anti-IRS-3 antibody. The resulting immune complexes were
submitted to SDS-PAGE and analyzed by Western blot with the anti-IRS-3 antibody. The autoradiograms corresponding to three independent
experiments were quantitated by scanning densitometry. Results are represented in the histograms. Middle panel, IRS-1/(IRS-3) and
IRS-1/(IRS-3F4) brown adipocytes were serum-starved for 15 h and incubated with insulin (100 nM) for 5 min. Cells were lysed, and 600 g
of total protein was immunoprecipitated with the anti-IRS-3 antibody. The immune complexes were washed and subjected to SDS-PAGE followed
by immunoblotting with anti-p85 and anti-IRS-3 antibodies, respectively. A representative experiment is shown. On the right the results are
depicted as arbitrary units of p85 association normalized to the amount of total IRS-3. B, serum-deprived brown adipocytes were stimulated with
insulin (10–100 nM) for 5 min. Total protein was used for an in vitro IRS-3-associated PI 3-kinase activity assay or analyzed by Western blot with
anti-phospho-Akt and anti-Akt antibodies. C, serum-deprived brown adipocytes were treated with various doses of wortmannin for 30 min before
the stimulation with insulin (100 nM) for a further 5 min. Cells were lysed, and total protein was used for an in vitro IRS-3-associated PI 3-kinase
activity or analyzed by Western blot with anti-phospho-Akt and anti-Akt antibodies. A representative experiment of four is depicted.
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of thermogenic-related genes in brown adipocytes. A key issue
arises about the nature of additional signals involved in the
UCP-1 expression and thermogenesis in the absence of IRS-1/
IRS-3-mediated insulin signaling. Among candidates, IGF-I or
TGF- play the same role as described for insulin (4, 38). In
addition, our data support the essential role played by the
FIG. 8. IRS-3F4 mutant fails to restore FAS and ADD1/SREBP-1c gene expression in IRS-1/ brown adipocytes. A, quiescent
wild-type, IRS-1/(IRS-3), and IRS-1/(IRS-3F4) brown adipocytes were serum-starved for 15 h and stimulated with insulin (10–100 nM) for
a further 12 h. Total RNA was isolated, submitted to Northern blot analysis, and hybridized with FAS and ADD1/SREBBP-1c probes. Represent-
ative autoradiograms are shown. Scanning densitometry of the mean of three-four independent experiments is shown on the right. B, quiescent
brown adipocytes were serum-starved for 15 h and stimulated with insulin (10–100 nM) for a further 24 h. Then cells were lysed, and equal amounts
of protein were submitted to SDS-PAGE followed by Western blot analysis with anti-FAS, anti-ADD1/SREBP-1c, and anti--actin antibodies.
Representative autoradiograms are shown. Scanning densitometry of the mean of three-four independent experiments is shown on the right.
FIG. 9. Specific role of IRS in insu-
lin signaling in brown adipocytes. In-
sulin signaling in brown adipocytes is reg-
ulated by the IRS family. IRS-1 (white
arrows) directs insulin signaling to prolif-
eration, lipid synthesis, and UCP-1 ex-
pression. However, in IRS-1-deficient
brown adipocytes, exogenously expressed
IRS-3 (black arrows) can modulate insu-
lin-induced lipid synthesis through PI
3-kinase, Akt, and ADD-1 but cannot re-
constitute insulin-induced UCP-1 expres-
sion. In addition IRS-2 (gray arrows)
maintains the insulin signaling through
PI 3-kinase and protein kinase C (PKC),
which results in an increase of glucose
uptake and Glut-4 translocation.
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sympathetic nervous enervation through the -adrenergic re-
ceptors in inducing UCP-1 gene expression in the absence of
IRS-dependent signaling.
Previous data have documented the essential contributions
of IRS-1/PI 3-kinase in mediating insulin regulation of FAS
and UCP-1 gene expression. This signaling pathway is not
required for triggering UCP-2 or UCP-3 gene expression (20).
Here we have investigated the role of an IRS-3F4 mutant
defective in binding sites for the Src homology 2 domains of
p85 regulatory subunit of PI 3-kinase (23). As expected, the
IRS-3F4 in IRS-1/ brown adipocytes failed to recruit p85 in
response to insulin (Fig. 7A). Surprisingly, insulin induced both
PI 3-kinase activity and Akt phosphorylation in IRS-1/
brown adipocytes expressing IRS-3F4 comparable with the ac-
tivation of these pathways in wild-type IRS-3 (Fig. 7B). More-
over, activation of PI 3-kinase in the IRS-3F4 cells was wort-
mannin-sensitive (Fig. 7, B and C, respectively). One likely
explanation for these observations is that in brown adipocytes
lacking IRS-1, insulin induces a weak association between p85
isoforms and the mutant IRS-3 sufficiently to promote PI 3-ki-
nase activation but not strongly enough to survive immunopre-
cipitation. These results should also be considered in light of
previous reports (33) demonstrating that IRS-3, but not IRS-1,
is constitutively localized in the plasma membrane in COS-1
cells. Thus, the IRS-34F mutant in response to insulin may
recruit and activate PI 3-kinase without an strong association
to p85 isoforms. Downstream of PI 3-kinase, IRS-3F4 signaling
activates Akt in response to insulin. However, IRS-3F4 signal-
ing failed to up-regulate ADD-1/SREBP-1c and FAS gene ex-
pression, which are impaired in the absence of IRS-1 (Fig. 8).
Our results suggest that Akt activation in response to insulin
can be dissociated from ADD-1/SREBP-1c expression in cells
expressing the IRS-3 mutant lacking canonical p85 binding
sites, which again may reflect differences in sub-cellular com-
partmentalization as compared with wild-type IRS-3. The cur-
rent data are incongruous with results reported from COS-7
cells where exogenous IRS-3 localized to the nucleus and acti-
vated transcription (39). Our data strongly suggest that insulin
requires IRS-3/p85/PI 3-kinase signaling to achieve transcrip-
tional activation of adipogenic-related genes in brown adipo-
cytes deficient for IRS-1.
In conclusion, introduction of IRS-3 signaling restores the PI
3-kinase/Akt pathway but fails to restore MAPK activation and
mitogenesis in brown adipocytes lacking IRS-1. Downstream
from PI 3-kinase, IRS-3 signaling restores ADD-1/FAS expres-
sion but not C/EBP/UCP-1. Although an IRS-3F4 mutant does
not recruit p85, insulin still activates PI 3-kinase/Akt in cells
expressing this recombinant molecule. However, IRS-3F4 sig-
naling fails to up-regulate ADD-1/FAS gene expression. Thus,
our data suggest that IRS-3 is capable of triggering the adipo-
genic-related gene expression in brown adipocytes that re-
quires IRS-3/p85/PI 3-kinase signaling to achieve transcrip-
tional activation. Finally, given that neither IRS-2 nor IRS-3
can fully reconstitute insulin action in IRS-1-deficient brown
adipocytes, our studies thoroughly implicate a unique function
for IRS-1 in brown adipose tissue (Fig. 9).
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